Upinder Bhambra

Upinder Bhambra has over 20 years of experience in the field of pharmacovigilance. Upinder most recently worked at Sage Therapeutics as the Senior Director and Head of Drug Safety and Pharmacovigilance (DSPV) Science. Prior to that, they held a similar role as Senior Director and Pharmacovigilance Scientist at Sage Therapeutics.

Before joining Sage Therapeutics, Upinder worked at Zogenix, Inc. as the Director of Pharmacovigilance for Europe. Upinder also worked at AbbVie as the Head of Pharmacovigilance in the UK.

Earlier in their career, Upinder served as the Director of Medical Writing at PrimeVigilance Ltd. and as the Senior Director of Pharmacovigilance at Shire. Upinder started their career as a Pharmacovigilance Scientist at MHRA, where they eventually became a Pharmacovigilance Assessor.

Overall, Upinder Bhambra has gained extensive experience and expertise in the field of pharmacovigilance, with a focus on drug safety and regulatory compliance.

Upinder Bhambra received a BSc in Biochemistry with Toxicology from the University of Surrey, where they attended from 1992 to 1996. Upinder later pursued a PhD at Imperial College London from 1997 to 2001. The field of study in their PhD program is not specified.